PixelBiosciences GmbH was founded in Heidelberg, Germany, with its headquarters in Suzhou, China. Our mission is to continuously provide advanced technical services, products, and tools to researchers, drug developers, and clinical diagnostic developers, who focus on new modality drugs. We are dedicated to empowering professionals engaged in fundamental research, cell and gene therapy, and RNA-based drug development. The company''s new Modality Enzyme Convergent Assembling (nMECA) platform offers a versatile, high-throughput, and cost-effective product portfolio, providing solutions for various unmet synthesis needs of customers. Currently, our customized sgRNA products have allowed us to establish a strong customer base, both locally and internationally, including prominent gene therapy companies and esteemed research institutions. In the future, our product pipeline will encompass cutting-edge areas such as gene editing drug development, spatial biology, proteomics, and more. To comprehensively support our research and production capabilities, we have already established fully automated intelligent laboratories and digital Good Manufacturing Practice (GMP) production lines in Suzhou.

Our services are now worldwide, benefiting various leading biopharmaceutical-technology companies, diagnostic device manufacturers, and research institutions. We are dedicated to delivering the highest quality products and services to our customers. In both academia and industry, we are fully engaged in fostering strong cooperation with our customers. Through our joint efforts, we aim to advance scientific progress and make a positive impact on the quality of life for all humanity and our planet.